Published in Microbes Infect on March 22, 2005
Herpes keratitis. Prog Retin Eye Res (2012) 1.55
Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol (2011) 1.53
Role for 3-O-sulfated heparan sulfate as the receptor for herpes simplex virus type 1 entry into primary human corneal fibroblasts. J Virol (2006) 1.44
Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol (2010) 1.38
Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol (2007) 1.24
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol (2012) 1.19
Enhanced antitumor efficacy of vasculostatin (Vstat120) expressing oncolytic HSV-1. Mol Ther (2009) 1.16
Pharmacologic and chemical adjuvants in tumor virotherapy. Chem Rev (2009) 1.10
Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol (2011) 1.07
Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res (2012) 1.05
Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog (2011) 1.04
IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J Immunol (2012) 1.04
On the role of regulatory T cells during viral-induced inflammatory lesions. J Immunol (2012) 1.02
IFN-gamma acts as anti-angiogenic cytokine in the human cornea by regulating the expression of VEGF-A and sVEGF-R1. Biochem Biophys Res Commun (2008) 1.01
Dendritic Cell Autophagy Contributes to Herpes Simplex Virus-Driven Stromal Keratitis and Immunopathology. MBio (2015) 0.98
Herpesvirus entry mediator and nectin-1 mediate herpes simplex virus 1 infection of the murine cornea. J Virol (2011) 0.96
Anti-VEGF monoclonal antibody-induced regression of corneal neovascularization and inflammation in a rabbit model of herpetic stromal keratitis. Graefes Arch Clin Exp Ophthalmol (2009) 0.93
Critical role of microRNA-155 in herpes simplex encephalitis. J Immunol (2014) 0.89
An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. J Virol (2011) 0.88
Effect of human apolipoprotein E genotype on the pathogenesis of experimental ocular HSV-1. Exp Eye Res (2008) 0.88
Substance P in the corneal stroma regulates the severity of herpetic stromal keratitis lesions. Invest Ophthalmol Vis Sci (2011) 0.87
Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis. J Immunol (2011) 0.87
Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Invest Ophthalmol Vis Sci (2013) 0.86
Absence of CXCL10 aggravates herpes stromal keratitis with reduced primary neutrophil influx in mice. J Virol (2013) 0.84
Suppression of transcription factor early growth response 1 reduces herpes simplex virus 1-induced corneal disease in mice. J Virol (2012) 0.83
Corneal lymphangiogenesis in herpetic stromal keratitis. Surv Ophthalmol (2014) 0.81
Resident Corneal Cells Communicate with Neutrophils Leading to the Production of IP-10 during the Primary Inflammatory Response to HSV-1 Infection. Int J Inflam (2012) 0.81
Cornea: Window to Ocular Immunology. Curr Immunol Rev (2011) 0.81
Morphometric analysis of postoperative corneal neovascularization after high-risk keratoplasty: herpetic versus non-herpetic disease. Graefes Arch Clin Exp Ophthalmol (2012) 0.81
H-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle. BMC Cell Biol (2013) 0.80
Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection. Virology (2006) 0.80
High-Risk Corneal Graft Rejection in the Setting of Previous Corneal Herpes Simplex Virus (HSV)-1 Infection. Invest Ophthalmol Vis Sci (2016) 0.80
Azacytidine treatment inhibits the progression of Herpes Stromal Keratitis by enhancing regulatory T cell function. J Virol (2017) 0.79
Tranylcypromine reduces herpes simplex virus 1 infection in mice. Antimicrob Agents Chemother (2014) 0.79
Robo 4 Counteracts Angiogenesis in Herpetic Stromal Keratitis. PLoS One (2015) 0.79
Role of miR-155 in the pathogenesis of herpetic stromal keratitis. Am J Pathol (2015) 0.78
Murine Corneal Inflammation and Nerve Damage After Infection With HSV-1 Are Promoted by HVEM and Ameliorated by Immune-Modifying Nanoparticle Therapy. Invest Ophthalmol Vis Sci (2017) 0.77
Lornoxicam suppresses recurrent herpetic stromal keratitis through down-regulation of nuclear factor-kappaB: an experimental study in mice. Mol Vis (2009) 0.77
Herpesvirus Entry Mediator on Radiation-Resistant Cell Lineages Promotes Ocular Herpes Simplex Virus 1 Pathogenesis in an Entry-Independent Manner. MBio (2015) 0.77
IL-6 Contributes to Corneal Nerve Degeneration after Herpes Simplex Virus Type I Infection. Am J Pathol (2016) 0.77
Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. Microbes Infect (2013) 0.76
Involvement of p63 in the herpes simplex virus-1-induced demise of corneal cells. J Biomed Sci (2010) 0.76
Potential function of miRNAs in herpetic stromal keratitis. Invest Ophthalmol Vis Sci (2013) 0.76
Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis. Invest Ophthalmol Vis Sci (2008) 0.75
Lychee flower extract inhibits proliferation and viral replication of HSV-1-infected corneal epithelial cells. Mol Vis (2016) 0.75
The inflammasome NLRP3 plays a protective role against a viral immunopathological lesion. J Leukoc Biol (2015) 0.75
Loss of Neurokinin-1 Receptor Alters Ocular Surface Homeostasis and Promotes an Early Development of Herpes Stromal Keratitis. J Immunol (2016) 0.75
Host immune cellular reactions in corneal neovascularization. Int J Ophthalmol (2016) 0.75
Toll-like receptor-associated keratitis and strategies for its management. 3 Biotech (2015) 0.75
Immunological aspects of acute and recurrent herpes simplex keratitis. J Immunol Res (2014) 0.75
Manipulating Glucose Metabolism during Different Stages of Viral Pathogenesis Can Have either Detrimental or Beneficial Effects. J Immunol (2017) 0.75
Natural regulatory T cells in infectious disease. Nat Immunol (2005) 6.49
Liver-infiltrating lymphocytes in chronic human hepatitis C virus infection display an exhausted phenotype with high levels of PD-1 and low levels of CD127 expression. J Virol (2006) 6.00
CD4+CD25+ T cells regulate virus-specific primary and memory CD8+ T cell responses. J Exp Med (2003) 4.56
CD4+CD25+ regulatory T cells control the severity of viral immunoinflammatory lesions. J Immunol (2004) 3.06
Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am J Pathol (2004) 1.70
Role of Tim-3/galectin-9 inhibitory interaction in viral-induced immunopathology: shifting the balance toward regulators. J Immunol (2009) 1.66
Differentiation of memory B and T cells. Curr Opin Immunol (2006) 1.59
DNA containing CpG motifs induces angiogenesis. Proc Natl Acad Sci U S A (2002) 1.55
Role of IL-17 and Th17 cells in herpes simplex virus-induced corneal immunopathology. J Immunol (2011) 1.53
Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog (2010) 1.52
Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J Clin Invest (2002) 1.47
Controlling herpes simplex virus-induced ocular inflammatory lesions with the lipid-derived mediator resolvin E1. J Immunol (2010) 1.38
Herpes keratitis in the absence of anterograde transport of virus from sensory ganglia to the cornea. Proc Natl Acad Sci U S A (2005) 1.38
CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J Virol (2004) 1.34
Role of regulatory T cells during virus infection. Immunol Rev (2013) 1.28
Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp Eye Res (2005) 1.26
Anti-inflammatory effects of FTY720 against viral-induced immunopathology: role of drug-induced conversion of T cells to become Foxp3+ regulators. J Immunol (2008) 1.26
Innate recognition network driving herpes simplex virus-induced corneal immunopathology: role of the toll pathway in early inflammatory events in stromal keratitis. J Virol (2007) 1.24
Qa-1b and CD94-NKG2a interaction regulate cytolytic activity of herpes simplex virus-specific memory CD8+ T cells in the latently infected trigeminal ganglia. J Immunol (2006) 1.19
Role of miR-132 in angiogenesis after ocular infection with herpes simplex virus. Am J Pathol (2012) 1.19
IL-10 and natural regulatory T cells: two independent anti-inflammatory mechanisms in herpes simplex virus-induced ocular immunopathology. J Immunol (2008) 1.17
In vitro-generated antigen-specific CD4+ CD25+ Foxp3+ regulatory T cells control the severity of herpes simplex virus-induced ocular immunoinflammatory lesions. J Virol (2008) 1.16
Treg control of antimicrobial T cell responses. Curr Opin Immunol (2006) 1.12
CXCR2-/- mice show enhanced susceptibility to herpetic stromal keratitis: a role for IL-6-induced neovascularization. J Immunol (2004) 1.11
Herpetic eye disease: immunopathogenesis and therapeutic measures. Expert Rev Mol Med (2004) 1.07
Mechanisms of pathogenesis in herpetic immunoinflammatory ocular lesions. Vet Microbiol (2002) 1.07
Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J Immunol (2011) 1.07
T cell immunoglobulin and mucin protein-3 (Tim-3)/Galectin-9 interaction regulates influenza A virus-specific humoral and CD8 T-cell responses. Proc Natl Acad Sci U S A (2011) 1.07
In vivo kinetics of GITR and GITR ligand expression and their functional significance in regulating viral immunopathology. J Virol (2005) 1.06
Induction of CD8 T-cell-specific systemic and mucosal immunity against herpes simplex virus with CpG-peptide complexes. J Virol (2002) 1.06
Mice transgenic for IL-1 receptor antagonist protein are resistant to herpetic stromal keratitis: possible role for IL-1 in herpetic stromal keratitis pathogenesis. J Immunol (2004) 1.05
Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization. Prog Retin Eye Res (2012) 1.05
Controlling viral immuno-inflammatory lesions by modulating aryl hydrocarbon receptor signaling. PLoS Pathog (2011) 1.04
Depletion of MCP-1 increases development of herpetic stromal keratitis by innate immune modulation. J Leukoc Biol (2006) 1.04
IL-17A differentially regulates corneal vascular endothelial growth factor (VEGF)-A and soluble VEGF receptor 1 expression and promotes corneal angiogenesis after herpes simplex virus infection. J Immunol (2012) 1.04
On the role of regulatory T cells during viral-induced inflammatory lesions. J Immunol (2012) 1.02
Immunization with chaperone-peptide complex induces low-avidity cytotoxic T lymphocytes providing transient protection against herpes simplex virus infection. J Virol (2002) 1.01
Galectin-1 reduces the severity of herpes simplex virus-induced ocular immunopathological lesions. J Immunol (2012) 1.00
Influence of galectin-9/Tim-3 interaction on herpes simplex virus-1 latency. J Immunol (2011) 1.00
Protective and pathological roles of virus-specific and bystander CD8+ T cells in herpetic stromal keratitis. J Immunol (2004) 0.99
Molecular adjuvants for mucosal immunity. Immunol Rev (2004) 0.97
Enhanced viral immunoinflammatory lesions in mice lacking IL-23 responses. Microbes Infect (2007) 0.96
Counteracting corneal immunoinflammatory lesion with interleukin-1 receptor antagonist protein. J Leukoc Biol (2004) 0.95
Emerged HA and NA mutants of the pandemic influenza H1N1 viruses with increasing epidemiological significance in Taipei and Kaohsiung, Taiwan, 2009-10. PLoS One (2012) 0.95
Mucosal application of plasmid-encoded IL-15 sustains a highly protective anti-Herpes simplex virus immunity. J Leukoc Biol (2005) 0.94
Elucidating the protective and pathologic T cell species in the virus-induced corneal immunoinflammatory condition herpetic stromal keratitis. J Leukoc Biol (2004) 0.94
Herpetic stromal keratitis in the absence of viral antigen recognition. Cell Immunol (2002) 0.94
Role of inflammatory cytokine-induced cyclooxygenase 2 in the ocular immunopathologic disease herpetic stromal keratitis. J Virol (2005) 0.93
Consensus statement on indications for anti-angiogenic therapy in the management of corneal diseases associated with neovascularisation: outcome of an expert roundtable. Br J Ophthalmol (2011) 0.93
Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo. J Immunol (2004) 0.92
Codelivery of CCR7 ligands as molecular adjuvants enhances the protective immune response against herpes simplex virus type 1. J Virol (2003) 0.89
Critical role of microRNA-155 in herpes simplex encephalitis. J Immunol (2014) 0.89
Tregs and infections: on the potential value of modifying their function. J Leukoc Biol (2011) 0.88
An anti-inflammatory role of VEGFR2/Src kinase inhibitor in herpes simplex virus 1-induced immunopathology. J Virol (2011) 0.88
Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis. J Immunol (2011) 0.87
IL-12 suppresses the expression of ocular immunoinflammatory lesions by effects on angiogenesis. J Leukoc Biol (2002) 0.87
TNFRSF25 agonistic antibody and galectin-9 combination therapy controls herpes simplex virus-induced immunoinflammatory lesions. J Virol (2012) 0.87
In vivo rescue of defective memory CD8+ T cells by cognate helper T cells. J Leukoc Biol (2005) 0.86
Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. J Immunol (2006) 0.86
Neuroprotectin D1 reduces the severity of herpes simplex virus-induced corneal immunopathology. Invest Ophthalmol Vis Sci (2013) 0.86
Viruses and autoimmunity. Autoimmunity (2006) 0.85
Heat-shock protein 70 acts as an effective adjuvant in neonatal mice and confers protection against challenge with herpes simplex virus. Vaccine (2005) 0.84
Pathogenic virus-specific T cells cause disease during treatment with the calcineurin inhibitor FK506: implications for transplantation. J Exp Med (2010) 0.83
Natural killer cells as novel helpers in anti-herpes simplex virus immune response. J Virol (2008) 0.83
Rescue of memory CD8+ T cell reactivity in peptide/TLR9 ligand immunization by codelivery of cytokines or CD40 ligation. Virology (2005) 0.82
Application of plasmid DNA encoding IL-18 diminishes development of herpetic stromal keratitis by antiangiogenic effects. J Immunol (2005) 0.82
Role of Stat4-mediated signal transduction events in the generation of aggressor CD4+ T cells in herpetic stromal keratitis pathogenesis. J Interferon Cytokine Res (2007) 0.82
Influence of DNA encoding cytokines on systemic and mucosal immunity following genetic vaccination against herpes simplex virus. Microbes Infect (2003) 0.82
Macrophage IL-12p70 signaling prevents HSV-1-induced CNS autoimmunity triggered by autoaggressive CD4+ Tregs. Invest Ophthalmol Vis Sci (2011) 0.82
Blocking mouse MMP-9 production in tumor cells and mouse cornea by short hairpin (sh) RNA encoding plasmids. Oligonucleotides (2005) 0.82
A strategy for selective, CD4+ T cell-independent activation of virus-specific memory B cells for limiting dilution analysis. J Immunol Methods (2006) 0.81
Quantitative analysis of herpes simplex virus type 1-specific memory B cells generated by different routes of infection. Virology (2006) 0.80
IL-21 and IL-15 cytokine DNA augments HSV specific effector and memory CD8+ T cell response. Mol Immunol (2009) 0.80
Control of viral immunoinflammatory lesions by manipulating CD200:CD200 receptor interaction. Clin Immunol (2008) 0.79
Antigenic peptides complexed to phylogenically diverse Hsp70s induce differential immune responses. Cell Stress Chaperones (2003) 0.79
Homeostatic expansion of CD4(+) T cells upregulates VLA-4 and exacerbates HSV-induced corneal immunopathology. Microbes Infect (2008) 0.78
Viral immunology: challenges associated with the progression from bench to clinic. Trends Immunol (2002) 0.78
A novel flow cytometry based assay for quantification of corneal angiogenesis in the mouse model of herpetic stromal keratitis. Exp Eye Res (2005) 0.78
Toll-like receptor ligand links innate and adaptive immune responses by the production of heat-shock proteins. J Leukoc Biol (2003) 0.77
Influence of CCR7 ligand DNA preexposure on the magnitude and duration of immunity. Virology (2003) 0.77
Application of FGF-2 to modulate herpetic stromal keratitis. Curr Eye Res (2006) 0.77
Potential function of miRNAs in herpetic stromal keratitis. Invest Ophthalmol Vis Sci (2013) 0.76
An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus. Hum Vaccin (2008) 0.76
Controlling herpetic stromal keratitis by modulating lymphotoxin-alpha-mediated inflammatory pathways. Microbes Infect (2013) 0.76
Regulation of microbial immunity: the suppressor cell renaissance. Viral Immunol (2005) 0.76
Non-mitogenic anti-CD3F(ab')2 monoclonal antibody: a novel approach to control herpetic stromal keratitis. Invest Ophthalmol Vis Sci (2008) 0.75
Viruses and autoimmunity. Autoimmunity (2005) 0.75